RESEARCH SUMMARY Study Title: Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma...
Vous n'êtes pas connecté
A new personalized cancer vaccine has shown encouraging results in preventing the return of kidney cancer after surgery. Researchers at Dana-Farber Cancer Institute tested the vaccine in nine patients with stage III or IV clear cell renal cell carcinoma (a form of kidney cancer). All patients remained cancer-free at a median follow-up of nearly three years. The […] The post New cancer vaccine could prevent kidney cancer recurrence appeared first on Knowridge Science Report.
RESEARCH SUMMARY Study Title: Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma...
Data analysis from a randomised clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham Cancer Center, USA, found...
THURSDAY, Feb. 6, 2025 -- Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell...
THURSDAY, Feb. 6, 2025 -- A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful,...
Before surgery, many patients go through a series of tests, such as blood work and heart rhythm checks. However, not all these tests are necessary. In...
WEDNESDAY, Jan. 29, 2025 -- Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study...
The three OTs in the department of renal transplant surgery were closed since 2022 due to faulty air-conditioning system
The three OTs in the department of renal transplant surgery were closed since 2022 due to faulty air-conditioning system
Researchers from the University of Brasília, Brazil, have investigated how cell-free DNA (cfDNA) levels in the blood change before, during, and after...
Researchers at The University of Hong Kong (HKU) have made an exciting discovery about how human cells protect DNA during cell division, offering new...